LOS ANGELES CAPITAL MANAGEMENT LLC
Position in BCRX — Biocryst Pharmaceuticals Inc
CIK 1177206
LOS ANGELES, CA
Position in BCRX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$12,870
-$452,658 QoQ
Shares Held
1,287
-97.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#279
of 316 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026LOS ANGELES CAPITAL MANAGEMENT LLC holds $64,712,202 across 30 Drug Manufacturers - Specialty & Generic names. BCRX ranks #23 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
203,548 | $34,305,979 | |
| 2 | VTRS |
Viatris Inc
|
751,406 | $11,932,327 | |
| 3 | LQDA |
Liquidia Corp
|
54,603 | $4,353,497 | |
| 4 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
50,786 | $3,247,764 | |
| 5 | COLL |
Collegium Pharmaceutical, Inc
|
89,443 | $3,237,836 | |
| 6 | PAHC |
Phibro Animal Health Corp
|
67,083 | $2,106,406 | |
| 7 | IRWD |
Ironwood Pharmaceuticals Inc
|
342,293 | $1,441,053 | |
| 8 | AKBA |
Akebia Therapeutics, Inc.
|
531,813 | $606,266 |
All Filings in BCRX
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,870 | 1,287 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $465,528 | 48,900 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $2,769,429 | 355,055 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $2,346,144 | 309,110 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $887,452 | 99,046 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $760,335 | 101,378 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $760,933 | 101,188 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $657,650 | 86,533 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $603,025 | 97,577 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $455,239 | 89,614 | Shares | Sole | 2024-04-05 | |
| 2023-12-31 | $319,446 | 53,330 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $234,546 | 33,128 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $229,658 | 32,622 | Shares | Sole | 2023-08-03 | |
| 2022-09-30 | $179,991 | 14,285 | Shares | Sole | 2022-11-02 | |
| 2021-03-31 | $314,761 | 30,950 | Shares | Sole | 2021-05-05 | |
| 2020-09-30 | $445,376 | 129,470 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $394,865 | 82,955 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $238,360 | 119,180 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||